Three-site reproducibility study completed by Tampa General Hospital, Mayo Clinic, and Baylor Scott & White HealthSufficient clinical samples ...

Wisdom Bioscience, Inc., a biotechnology company pioneering non-invasive oral cancer diagnostics, today announced the formation of its Scientific Advisory Board (SAB) following the close of an initial ...

Insight Molecular Diagnostics completes major milestones to support GraftAssureDx test kit trial for in vitro diagnostic for US FDA submission: Nashville, Tennessee Thursday, Marc ...

5,000-participant, multi-center registry supported by iMDx’s central lab and transplant center partners New hospital-based data seeks to further differentiate pending kitted assay that measures ...

When Domain Associates led Xagenic Inc.’s recent $20 million Series B, it marked the eighth diagnostics investment the firm had made with its $500 million eighth fund. The partners say they’ve ...

DelveInsight's Companion Diagnostics Market Insights report provides the current and forecast market analysis, individual ...

Opportunities lie in integrating advanced diagnostics and digital solutions, leveraging partnerships, and enhancing supply ...

IMDX is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of IMDX shares has decreased $0.10 since the market last closed. This is a 1.74% ...

In recent times, investors have been increasingly drawn to companies operating in the molecular diagnostics space, a rapidly growing segment within the broader in-vitro diagnostics (IVD) market.

In the following sections, we highlight ethical concerns about early adoption of molecular diagnostic testing without solid evidence or guidelines and offer practical guidance for ethical ...

Noida (Uttar Pradesh) [India], February 25: As India advances its ambition to become a global centre for healthcare ...

Molecular diagnostics market size to reach USD 38.01 billion by 2034: Polaris Market Research: United States Thursday, February 19, 2026, 09:00 Hrs [IST] The molecular diagnostics ...